Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Feb 11, 2022
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2022Buy(P)4K$1.49$6K11.2M
Feb 10, 2022Buy(P)3K$1.45$4K11.2M
Feb 9, 2022Buy(P)24K$1.45$34K11.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-008917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML